189 related articles for article (PubMed ID: 33852863)
1. CD169
Tacconi C; Commerford CD; Dieterich LC; Schwager S; He Y; Ikenberg K; Friebel E; Becher B; Tugues S; Detmar M
Cell Rep; 2021 Apr; 35(2):108993. PubMed ID: 33852863
[TBL] [Abstract][Full Text] [Related]
2. Reduced number of CD169
Strömvall K; Sundkvist K; Ljungberg B; Halin Bergström S; Bergh A
Prostate; 2017 Nov; 77(15):1468-1477. PubMed ID: 28880401
[TBL] [Abstract][Full Text] [Related]
3. The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer.
Shiota T; Miyasato Y; Ohnishi K; Yamamoto-Ibusuki M; Yamamoto Y; Iwase H; Takeya M; Komohara Y
PLoS One; 2016; 11(11):e0166680. PubMed ID: 27861544
[TBL] [Abstract][Full Text] [Related]
4. Loss of CD169
Topf MC; Harshyne L; Tuluc M; Mardekian S; Vimawala S; Cognetti DM; Curry JM; Rodeck U; Luginbuhl A
Otolaryngol Head Neck Surg; 2019 Jul; 161(1):67-73. PubMed ID: 30744470
[TBL] [Abstract][Full Text] [Related]
5. CD169
Camara A; Lavanant AC; Abe J; Desforges HL; Alexandre YO; Girardi E; Igamberdieva Z; Asano K; Tanaka M; Hehlgans T; Pfeffer K; Pfeffer S; Mueller SN; Stein JV; Mueller CG
Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35031565
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma.
Ohnishi K; Yamaguchi M; Erdenebaatar C; Saito F; Tashiro H; Katabuchi H; Takeya M; Komohara Y
Cancer Sci; 2016 Jun; 107(6):846-52. PubMed ID: 26991548
[TBL] [Abstract][Full Text] [Related]
7. Melanoma growth and lymph node metastasis is independent of host CD169 expression.
Muhsin-Sharafaldine MR; Saunderson SC; Dunn AC; McLellan AD
Biochem Biophys Res Commun; 2017 May; 486(4):965-970. PubMed ID: 28359758
[TBL] [Abstract][Full Text] [Related]
8. CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis.
Asano T; Ohnishi K; Shiota T; Motoshima T; Sugiyama Y; Yatsuda J; Kamba T; Ishizaka K; Komohara Y
Cancer Sci; 2018 May; 109(5):1723-1730. PubMed ID: 29520898
[TBL] [Abstract][Full Text] [Related]
9. Co-localization of CD169
Björk Gunnarsdottir F; Auoja N; Bendahl PO; Rydén L; Fernö M; Leandersson K
Oncoimmunology; 2020 Nov; 9(1):1848067. PubMed ID: 33299660
[TBL] [Abstract][Full Text] [Related]
10. Possible functions of CD169-positive sinus macrophages in lymph nodes in anti-tumor immune responses.
Komohara Y; Ohnishi K; Takeya M
Cancer Sci; 2017 Mar; 108(3):290-295. PubMed ID: 28002629
[TBL] [Abstract][Full Text] [Related]
11. Natural compounds that regulate lymph node sinus macrophages: Inducing an anti-tumor effect by regulating macrophage activation.
Fujiwara Y; Saito Y; Shiota T; Cheng P; Ikeda T; Ohnishi K; Takeya M; Komohara Y
J Clin Exp Hematop; 2018; 58(1):17-23. PubMed ID: 29553092
[TBL] [Abstract][Full Text] [Related]
12. CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma.
Ohnishi K; Komohara Y; Saito Y; Miyamoto Y; Watanabe M; Baba H; Takeya M
Cancer Sci; 2013 Sep; 104(9):1237-44. PubMed ID: 23734742
[TBL] [Abstract][Full Text] [Related]
13. High CD169 expression in lymph node macrophages predicts a favorable clinical course in patients with esophageal cancer.
Takeya H; Shiota T; Yagi T; Ohnishi K; Baba Y; Miyasato Y; Kiyozumi Y; Yoshida N; Takeya M; Baba H; Komohara Y
Pathol Int; 2018 Dec; 68(12):685-693. PubMed ID: 30516869
[TBL] [Abstract][Full Text] [Related]
14. CD169(+) macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer.
Wu AC; He Y; Broomfield A; Paatan NJ; Harrington BS; Tseng HW; Beaven EA; Kiernan DM; Swindle P; Clubb AB; Levesque JP; Winkler IG; Ling MT; Srinivasan B; Hooper JD; Pettit AR
J Pathol; 2016 Jun; 239(2):218-30. PubMed ID: 27174786
[TBL] [Abstract][Full Text] [Related]
15. Correlation of the Levels of microRNA with Cell Composition of Axillary Lymph Node in Wistar Rats with Breast Cancer.
Kabakov AV; Lykov AP; Kazakov OV; Poveshchenko AF; Poveshchenko OV; Kim II; Bondarenko NA; Strunkin DN; Letyagin AY; Konenkov VI
Bull Exp Biol Med; 2020 Feb; 168(4):500-502. PubMed ID: 32157513
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer cells promote CD169
Jing W; Guo X; Wang G; Bi Y; Han L; Zhu Q; Qiu C; Tanaka M; Zhao Y
Int Immunopharmacol; 2020 Jan; 78():106012. PubMed ID: 31865052
[TBL] [Abstract][Full Text] [Related]
17. Correlation Analysis of Morphological Changes of Structural and Functional Areas of Mesenteric Lymph Nodes with Cytokines of Lymph of Thoracic Lymphatic Duct in Experimental Breast Cancer.
Kazakov OV; Raiter TV; Poveshchenko AF; Orlov NB; Poveshchenko OV; Kabakov AV; Kim II; Bondarenko NA; Strunkin DN; Lykov AP; Letyagin AY; Konenkov VI
Bull Exp Biol Med; 2020 Feb; 168(4):512-516. PubMed ID: 32147763
[TBL] [Abstract][Full Text] [Related]
18. Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration.
Kawaguchi S; Kawahara K; Fujiwara Y; Ohnishi K; Pan C; Yano H; Hirosue A; Nagata M; Hirayama M; Sakata J; Nakashima H; Arita H; Yamana K; Gohara S; Nagao Y; Maeshiro M; Iwamoto A; Hirayama M; Yoshida R; Komohara Y; Nakayama H
Cancer Immunol Immunother; 2022 Sep; 71(9):2127-2139. PubMed ID: 35044489
[TBL] [Abstract][Full Text] [Related]
19. SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions.
Pucci F; Garris C; Lai CP; Newton A; Pfirschke C; Engblom C; Alvarez D; Sprachman M; Evavold C; Magnuson A; von Andrian UH; Glatz K; Breakefield XO; Mempel TR; Weissleder R; Pittet MJ
Science; 2016 Apr; 352(6282):242-6. PubMed ID: 26989197
[TBL] [Abstract][Full Text] [Related]
20. Importance of CD200 expression by tumor or host cells to regulation of immunotherapy in a mouse breast cancer model.
Curry A; Khatri I; Kos O; Zhu F; Gorczynski R
PLoS One; 2017; 12(2):e0171586. PubMed ID: 28234914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
